FindTrial
Sign In

FOXK1 inhibits autophagy in colorectal cancer cells through PI3K/AKT signaling pathway to induce EMT to promote tumor progression

FOXK1 inhibits autophagy in colorectal cancer cells through PI3K/AKT signaling pathway to induce EMT to promote tumor progression

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500099655
Enrollment
Unknown
Registered
2025-03-26
Start date
2025-03-10
Completion date
Unknown
Last updated
2025-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Paracancerous group:None
Colorectal cancer tissue group:None

Sponsors

Ningbo Medical Centre Lihuili Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Colorectal cancer tissue chips are collected

Exclusion criteria

Exclusion criteria: 1.Patients with chemoradiotherapy or targeted therapy

Design outcomes

Primary

MeasureTime frame
PCR detection of target gene expression;—

Countries

China

Contacts

Public ContactWang Yu

Ningbo Medical Centre Lihuili Hospital

494971496@qq.com+86 574 87018617

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026